• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING Back to Search Results
Model Number M004RC64S0
Device Problems Failure to Capture (1081); High impedance (1291); Over-Sensing (1438); Pacing Problem (1439); Device Sensing Problem (2917); Device Dislodged or Dislocated (2923); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Discomfort (2330); No Known Impact Or Consequence To Patient (2692)
Event Date 09/03/2018
Event Type  Injury  
Event Description
It was reported that the patient experienced a cardiac tamponade.During an ablation procedure to treat an arrhythmia, the physician used 8.5f non-boston scientific sheath and an intellamap orion catheter for positioning and ablation.During mapping, when the orion catheter reached the target position at right ventricular outflow tract (rvot), the patient said her chest felt uncomfortable.X ray showed cardiac tamponade.Blood pressure decreased from 120/80mmhg to 90/60mmhg.Pericardiocentesis was performed and 260ml of non-clotting blood was drawn.The blood pressure recovered to 120/70mmhg.Rescue was successful and physician decided to stop surgery.The patient's consciousness was clear during surgery and rescue.The patient was sent to intensive care unit for observation.It was suspected that the event was related to the "too deep" position of the sheath, but it was hard to judge if the event was related to the orion.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and inner/outer insulation integrity.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no anomalies.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.This supplemental correction report is being filed to correct the report number in a previously submitted supplemental report (follow-up number 001) which was accepted by fda on 12/19/2018 04:40 pm ct.The report number is being corrected from: 2124215-2018-62258 to: 2134265-2018-61418.
 
Event Description
This supplemental report is being filed because the product was returned and analyzed.
 
Event Description
It was reported that the patient experienced a cardiac tamponade.During an ablation procedure to treat an arrhythmia, the physician used 8.5f non-boston scientific sheath and an intellamap orion catheter for positioning and ablation.During mapping, when the orion catheter reached the target position at right ventricular outflow tract (rvot), the patient said her chest felt uncomfortable.X ray showed cardiac tamponade.Blood pressure decreased from 120/80mmhg to 90/60mmhg.Pericardiocentesis was performed and 260ml of non-clotting blood was drawn.The blood pressure recovered to 120/70mmhg.Rescue was successful and physician decided to stop surgery.The patient's consciousness was clear during surgery and rescue.The patient was sent to intensive care unit for observation.It was suspected that the event was related to the "too deep" position of the sheath, but it was hard to judge if the event was related to the orion.The device was returned for analysis.Visual inspection showed no visible abnormalities.The electrical test was performed and the device passed the test.The device passed all relevant testing/inspection.
 
Manufacturer Narrative
This supplemental correction report is being filed to correct the report number in a previously submitted supplemental report (follow-up number 001) which was accepted by fda on 12/12/2018 02:58 pm ct.The report number is being corrected from: 2134265-2018-63947 to: 2134265-2018-61418.This report is follow-up # 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER
Type of Device
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key7920038
MDR Text Key122147922
Report Number2134265-2018-61418
Device Sequence Number1
Product Code DRF
UDI-Device Identifier08714729841968
UDI-Public08714729841968
Combination Product (y/n)N
PMA/PMN Number
K143481
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 01/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/19/2019
Device Model NumberM004RC64S0
Device Catalogue Number87035
Device Lot Number0021762353
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/25/2018
Initial Date Manufacturer Received 09/11/2018
Initial Date FDA Received09/28/2018
Supplement Dates Manufacturer Received11/19/2018
12/04/2018
Supplement Dates FDA Received01/22/2019
01/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SHEATH: ABBOTT SL1, 8.5F; SHEATH: ABBOTT SL1, 8.5F
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age58 YR
-
-